Free Trial

Stratec (ETR:SBS) Stock Price Down 0.4% - Here's What Happened

Stratec logo with Medical background

Stratec SE (ETR:SBS - Get Free Report) shares fell 0.4% during mid-day trading on Monday . The company traded as low as €23.45 ($27.27) and last traded at €23.55 ($27.38). 14,052 shares changed hands during trading, an increase of 125% from the average session volume of 6,253 shares. The stock had previously closed at €23.65 ($27.50).

Stratec Stock Performance

The company has a debt-to-equity ratio of 66.97, a current ratio of 2.52 and a quick ratio of 1.65. The firm has a market cap of $282.92 million, a price-to-earnings ratio of 28.26, a P/E/G ratio of 10.43 and a beta of 0.16. The firm has a fifty day simple moving average of €25.05 and a two-hundred day simple moving average of €27.93.

About Stratec

(Get Free Report)

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Stratec Right Now?

Before you consider Stratec, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stratec wasn't on the list.

While Stratec currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?
These 3 Penny Stocks Could Surprise Everyone This Summer!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines